Jeff Chodakewitz - Articles and news items

Merck logo

Merck presents new Pharmacokinetic data on ISENTRESS® (raltegravir) at 14th European AIDS conference

Industry news / 16 October 2013 / Merck

Company confirms development program for investigational once daily (QD) dosing regimen of ISENTRESS…

Merck logo

Merck provides update on cardiovascular development program

Industry news, News / 26 August 2012 / Merck

Merck provided an update on the development programs for vorapaxar, extended release niacin/laropirprant and anacetrapib…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+